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DOI 10.1186/s12891-017-1595-0RESEARCH ARTICLE Open AccessGeneralised joint hypermobility and
shoulder joint hypermobility, – risk of
upper body musculoskeletal symptoms and
reduced quality of life in the general
population
Birgit Juul-Kristensen1*, Lasse Østengaard1, Sebrina Hansen1, Eleanor Boyle1,2, Tina Junge1,3 and Lise Hestbaek1Abstract
Background: Generalised Joint Hypermobility (GJH) is a hereditary condition with an ability to exceed the joints
beyond the normal range. The prevalence of GJH in the adult population and its impact on upper body
musculoskeletal health and quality of life has mostly been studied in selected populations. The aims of this study
were therefore, firstly to study the prevalence of GJH and GJH including shoulder hypermobility (GJHS), in the
general Danish adult population; secondly to test the associations between GJH or GJHS and upper body
musculoskeletal symptoms and health-related quality of life (HRQoL).
Methods: The study was cross-sectional where 2072 participants, aged 25–65, randomly extracted from the Danish
Civil Registration System), were invited to answer a questionnaire battery (Five-Part Questionnaire for classification
of GJH, Standardised Nordic Questionnaire for musculoskeletal symptoms, EuroQoL-5D for HRQoL).
Results: Totally 1006 (49%) participants responded. The prevalence of GJH and GJHS were 30% (n = 300) and 5% (n = 51),
respectively. Compared with Non GJH (NGJH), participants with GJH and GJHS had Odds Ratio (OR) of 1.5-3.5 for upper
body musculoskeletal symptoms within the last 12 months (mostly shoulders and hands/wrists). GJH and GJHS also had
OR 1.6–4.4 for being prevented from usual activities, mostly due to shoulder and neck symptoms. Furthermore, GJH and
GJHS had OR 2.2–3.1 for upper body musculoskeletal symptoms lasting for more than 90 days (neck, shoulders, hand/
wrists), and 1.5–3.5 for reduced HRQoL (all dimensions, but anxiety/depression) compared with NGJH. Generally, most OR
for GJHS were about twice as high as for those having GJH alone.
Conclusions: GJH and GJHS are frequently self-reported musculoskeletal conditions in the Danish adult population.
Compared with NGJH, GJH and especially GJHS, present with higher OR for upper body musculoskeletal symptoms, more
severe symptoms and decreased HRQoL.
Keywords: Generalised joint hypermobility, Shoulder joint hypermobility, Upper body musculoskeletal symptoms,
shoulder symptoms, Neck symptoms, Epidemiology, Quality of life* Correspondence: BJuul-Kristensen@health.sdu.dk
1Institute of Sports Science and Clinical Biomechanics, University of Southern
Denmark, Odense, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Juul-Kristensen et al. BMC Musculoskeletal Disorders  (2017) 18:226 Page 2 of 9Background
Musculoskeletal symptoms like pain, ache and dis-
comfort is a burden for society due to its enormous
societal costs. One of the musculoskeletal conditions,
Generalised Joint Hypermobility (GJH), is a hereditary
condition with an exaggerated ability to exceed the
joints beyond the normal range of motion, defined by
a certain number of positive joint mobility tests [1].
GJH has been found to be associated with musculo-
skeletal pain [2, 3], fibromyalgia [4], anxiety [5, 6],
and musculoskeletal injuries [7]. GJH is even antici-
pated to be a risk factor for premature osteoarthritis
[2], but this has never been confirmed.
Prevalence rates of adults with GJH measured clinic-
ally vary from 2% to 57% and these are dependent upon
the test and criteria used, and the population investi-
gated [2, 8]. High prevalence rates of GJH have been
identified within specific sports/performing art activities,
such as ballet dancing, gymnastics, swimming, and
among musicians [9–12]. Most studies reporting preva-
lence of GJH include study samples from specific ethnic
areas, age groups, or participants from specific health
care clinics. But prevalence rates of GJH in a general
adult population are lacking.
Tests for classifying GJH by clinical tests are the
Beighton score, consisting of nine tests of satisfactory
reproducibility [1, 13, 14]. For use in epidemiological
studies, a validated questionnaire, the Five-part Ques-
tionnaire (5-PQ), has been developed taking actual, as
well as historical information of hypermobility into
consideration [3, 15, 16]. Using the 5-PQ the British
population prevalence of GJH was 18% (based on
physician consultations of 46,000 adults already in-
cluded in a study of chronic widespread pain) [17],
and 37% (based on 2,523 Brazilian university stu-
dents) [15]. Due to the current prevalence rates being
based only on selected populations, there is a need
for a solid estimate of the prevalence in a random
sample of the general adult population.
Previous studies have found an association between
GJH and self-reported shoulder injuries in adult pa-
tient populations (e.g. Joint Hypermobility Syndrome
and Ehlers Danlos Syndrome, Hypermobile Type)
[18, 19], patients from emergency units with GJH/
GJH with shoulder joint hypermobility (GJHS) and
traumatic shoulder injuries [20], and in non-patient
populations like military personnel [21], and adoles-
cents with GJH [22]. Again, these associations were
primarily studied in selected populations. In the gen-
eral working population one of the contributors to
neck/shoulder symptoms is reported to be work-
related exposure [23, 24], but GJH/GJHS as another
potential contributor to neck/shoulder symptoms in
the general population is yet to be explored.In summary, since former studies have reported preva-
lence of GJH, and an association between GJH and mus-
culoskeletal symptoms using selected study-samples well
known in the health care, there is potential risk of over-
reporting. Therefore, the aim of this study was to deter-
mine the prevalence of GJH and GJHS in the general
adult population in Denmark, and further investigate the
association of GJH/GJHS with musculoskeletal symp-
toms in the upper part of the body, as well as with
HRQoL.
Methods
Population
The study was cross-sectional and the target population
was adults aged 25 to 65 years, living with a permanent
home address in Denmark on January 2015. The data
collection period was from January 2015 to June 2015.
For the sampling population an external institution,
the governmental health authority State Serum Institute,
approved the project (accept number FSEID-00001211,
Date 24-11-2014), and accepted to extract a random list
of names and home addresses of the adult population in-
cluded in the Danish Civil Registration System (DCRS),
a register of all residents in Denmark.
The sampling method included sending out a posted
invitation letter about the study to everyone on the
random list. The letter contained an internet link
with a personal code to an online questionnaire that
was hosted by SurveyXact [25] and instructions on
how to fill out the questionnaire. Using a modified
Dillman approach to increase response rates [26],
non-responders received email reminders three and
six weeks after the first invitation letter. The Regional
Scientific Ethical Committee for Southern Denmark
did not consider this study to be invasive and there-
fore, no ethics approval was warranted (12/5-2014;
komite@rsyd.dk). Informed consent to participate ac-
cording to the Declaration of Helsinki [27] was as-
sumed based on a returned completed questionnaire.
Questionnaire battery
The questionnaire battery contained the following
questionnaires and questions: 5-PQ, Standardised
Nordic Questionnaire (SNQ), EuroQoL-5D-5 L (EQ-
5D-5 L), demographics (e.g., age, sex and current
work status with response options of ‘employed, stu-
dent, unemployed, absent due to illness, retired, early
retired, or other’) and anthropometric questions (e.g.,
height and weight).
The 5-PQ consists of five questions that are used to
determine the presence of GJH [3]. The questions are:
Q1)’Can you now (or could you ever) place your hands
flat on the floor without bending your knees?’ (Yes/No),
Q2) ‘Can you now (or could you ever) bend your thumb
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you amuse your friends by contorting your body into
strange shapes or could you do the splits?’ (Yes/No),
Q4) ‘As a child or teenager did your shoulder or kneecap
dislocate on more than one occasion?’ (Yes/No), and
Q5) ‘Do you consider yourself double-jointed?’ (Yes/No).
The 5-PQ has shown satisfactory test-retest reliability
and criterion validity compared with clinical tests for
GJH [15, 16]. Further, the 5-PQ has been linguistically
translated and cross-culturally tested in a Danish patient
and non-patient adult population [28]. The cut-point of
two positive answers out of the five questions has been
defined as the criteria for GJH. The 5-PQ questionnaire
has been validated in two cohorts composed of patients
and non-patients with sensitivities of 77% and 85% and
specificities of 80% and 89% when compared against the
gold standard of a clinical examination [3].
To determine the prevalence of GJHS the following
question about shoulder joint hypermobility was in-
cluded in the questionnaire battery: ‘Do you have in-
creased range of motion, or are you loose in one or both
shoulders?’ (Yes/No). This question has not undergone
psychometric testing, but is based on current clinical
knowledge and two previous studies that showed signifi-
cant associations between GJH/GJHS and shoulder dis-
locations/subluxations [20, 21]. Participants who
answered ‘Yes’ to the previous mentioned question, were
classified as GJHS, provided that they were also catego-
rized as having GJH.
The SNQ is a widely used questionnaire for assessing
presence and severity of musculoskeletal trouble, which
we refer to as symptoms in this paper [29]. To illustrate
the body region that each question pertains to a body
diagram with the appropriate area(s) (i.e., neck, shoul-
ders, elbows, wrists/hands) shaded in is located next to
each question. SNQ has obtained satisfactory reliability
and validity against clinical examinations [30–32].
Participants were asked whether they had any musculo-
skeletal symptoms (pain, ache, discomfort) in these body
regions within the last year (yes/no) and about the sever-
ity. The questions about severity included whether their
symptoms had prevented them from performing their
usual activities (at home/outside their home) (yes/no),
and for how many days they had had these symptoms
within the last year (0 days/1–7 days/8–30 days/31–90
days/above 90 days). For the analysis purpose, the num-
ber of days was collapsed into: 0 days, 1 to 90 days and
more than 90 days, the latter being indicative of a
chronic musculoskeletal condition [33, 34].
The EQ-5D-5 L consists of two parts. The first part is
composed of five dimensions (i.e., mobility, self-care,
usual activities, pain/discomfort and anxiety/depression)
about today’s perceived health status [35, 36]. Each di-
mension is rated using a five-level ordinal scale asfollows: 1) no problems, 2) slight problems, 3) moderate
problems, 4) severe problems, and 5) extreme problems
[37]. The Index calculator of the EuroQol Research
Foundation was used to calculate the total index-score
of the HRQoL, ranging from one to below null [38]. A
score of one indicates that the participants perceived
their health at the best possible state and a score below
null that the participants perceived their health worse
than death, with null as the reference score of death. In
patients with shoulder instability problems, EQ-5D-5 L
has shown satisfactory psychometric properties [39, 40].
The second part of the EQ-5D-5 L involves the partici-
pants marking their today’s perceived health on a visual
analogue scale (VAS), ranging from ‘the best health you
can imagine’ to ‘the worst health you can imagine’, called
the EuroQol VAS. This scale ranges from 0 to 100, with
a score of 100 as the best possible health and null as the
worst possible health.Statistical analyses
Complete case analysis was conducted because 17 par-
ticipants did not complete the entire questionnaire. We
decided not to do imputation because we felt the miss-
ing was not random and we did not want to introduce
any bias to the data [41].
Data was tested for normality (Shapiro Wilk, histogram
distributions) and was found not to be normal. Descriptive
statistics displaying median with interquartile range (IQR)
for continuous data and percentage with 95% confidence
interval for categorical data were used to present demo-
graphic data. Group differences on demographics in par-
ticipants with Non Generalised Joint Hypermobility
(NGJH) versus GJH, and NGJH versus GJHS were tested
with Wilcoxon rank-sum (Mann–Whitney U-test) for
continuous data and with Chi-square or Fisher’s exact test
for categorical data. Due to the number of comparisons
(68 comparisons: 2 groups (GJH and GJHS), 2 models
(crude and adjusted models), 4 body regions/5 dimensions
in EQ-5D-5 L, four questions (prevalence within the last
year, being prevented from performing their usual activ-
ities, having had musculoskeletal symptoms for more than
90 days, EQ-5D-5 L)), the level of significance for all ana-
lyses was adjusted by the Bonferroni method, implying
that the statistical level of significance corresponds to p <
0.025. To limit the number of tables, data on preva-
lence and OR for musculoskeletal symptoms lasting
for more than 90 days per year have only been pre-
sented in the text.
Tests for associations between GJH/GJHS and the
nominal/ordinal outcomes for reporting musculoskeletal
symptoms, in addition to the five dimensions of the EQ-
5D-5 L, were performed with either logistic or ordered/
multinomial logistic regression analyses (crude and
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OR and 95% confidence Interval (95% CI).
Sample size calculation was based on an estimated
prevalence of musculoskeletal symptoms in the gen-
eral adult population in Denmark, corresponding to
approximately 15% [42], and an estimated prevalence
of musculoskeletal symptoms in adults with GJH of
30% [19]. The prevalence of GJH was set to a ratio of
1:6, which equals 16.6%. A two-sample proportion Chi-
square test, with significance level of 5% and power of
80% in a two-sided test, showed that 518 respondents
were required to detect a significant difference in muscu-
loskeletal symptoms between those with GJH/GJHS and
NGJH. Due to an expected response rate of 28% [17], the
current survey was sent out to four times as many partici-
pants as required (4 × 518), corresponding to 2072 partici-
pants. All statistical analyses were conducted in STATA
13, StataCorp. 2013.
Results
Of the 2072 randomly generated names and addresses
from the DCRS, 16 addresses were found to be invalid.
Therefore, a total of 2056 participants were invited to
participate and 1006 participants responded, resulting in
a response rate of 49%, of which 989 (98%) participants
filled out the entire questionnaire. Fourteen (1.4%) par-
ticipants declined to participate, 16 (1.6%) were unable
to participate, 18 letters were returned to sender (1.8%),
and 1050 (51%) did not access the questionnaire using
the Internet address (Fig. 1).
The median age of the cohort was 50 years (IQR 40–
57 years) and participants with GJH were slightly youn-
ger (48 years vs 50 years; p = 0.025) and more often
females (GJH/GJHS 77% or 76% vs 47% in NGJH; p <
0.001) than participants with NGJH (Table 1). There
were no significant group differences in Body Mass
Index and work-related status.
Prevalence of GJH and GJHS
The prevalence of GJH was 30% (n = 300) and the preva-
lence of GJHS was 5% (n = 51) (Fig. 1). Of those classi-
fied with GJH (n = 300), almost all of the participants
(90.3%, n = 271) answered ‘Yes’ to Q1) ‘Can you now (or
could you ever) place your hands flat on the floor with-
out bending your knees?’. For those classified with GJHS
(n = 51), both Q1 and Q5, ‘Do you consider yourself
double-jointed?’ (Q5), were most frequently answered
positively, corresponding to 82.4% (n = 42) and 84.3% (n
= 43), respectively (not in Tables).
Musculoskeletal symptoms in the upper body regions
Participants with GJH and GJHS were more likely to re-
port musculoskeletal symptoms within the last
12 months for the upper body sites than NGJH. Thehighest proportion of region specific musculoskeletal
symptoms was for participants with GJHS. This was 76%
for the shoulder (95%CI: 64–89) (not in tables). Overall,
participants with GJHS had higher OR of having symp-
toms with their upper body regions (especially shoul-
ders, hands/wrists) than NGJH participants (Table 2).
The adjusted analyses were similar to the crude analyses
except for the neck, which did not reach significance in
the adjusted analyses.
The severity of the region specific musculoskeletal
symptoms was determined by whether it prevented the
participants from performing their usual daily activities
(in/outside their home) and by the duration of their
symptoms. Participants with GJH and GJHS were more
likely to have difficulties performing their usual activities
due to symptoms in their upper body regions (especially
neck, shoulders), except for the elbows in GJH (not in
tables). Neck and shoulder regions also had the highest
OR for positive associations with difficulties in perform-
ing their usual activities, and the OR for GJHS were gen-
erally about twice as high than GJH only (Table 2).
With respect to musculoskeletal symptoms lasting for
more than 90 days per year, only neck symptoms were
reported significantly more often for GJH (24%) and for
GJHS (32%) than for NGJH (15%) (not presented in
Tables). Positive associations for musculoskeletal symp-
toms lasting for more than 90 days per year were seen in
all regions (except for the elbow), with OR between 2.18
and 3.11 (not presented in Tables).
Health related quality of life (HRQoL)
Participants with GJH (median EuroQoL VAS = 80) or
with GJHS (median = 75) reported significantly lower
HRQoL score than the NGJH participants (median = 85,
p < 0.001) (Table 1). Similarly, the EQ-5D-5 L Index was
significantly lower for the participants with either GJH
or GJHS. The same was observed for each of the five di-
mensions of the EQ-5D-5 L Index. OR ranged from 2.8
to 3.5 for GJHS, and from 1.5 to 1.9 for GJH when com-
pared with NGJH, showing OR for GJHS generally being
twice as high as for those with GJH alone (Table 3).
Discussion
The estimated prevalence was 30% for GJH and 5% for
GJHS. Compared with NGJH, participants with GJH and
GJHS had higher odds for upper body musculoskeletal
symptoms within the last 12 months (mostly in the
shoulders and hands/wrists), and higher odds of being
prevented from performing their usual activities in/out-
side their home (mostly due to neck and shoulder symp-
toms). Furthermore, GJH and GJHS had increased OR
of 2.2-3.1 for upper body musculoskeletal symptoms in
all regions lasting for more than 90 days (except in el-
bows), and both groups had increased OR for reduced
Fig. 1 Flowchart of the participant recruitment
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GJHS were about twice as high as for those having GJH
alone.
Compared with other countries, the current preva-
lence of 30% is similar to a Brazilian study of univer-
sity students that reported a prevalence of 37% usingthe 5-PQ (and in the same study 34% using the
Beighton score of at least 4/9) [15]. However, the
present prevalence is higher than a British survey of
adults reporting a prevalence of 18% also using the 5-
PQ [17]. This may be due to the participants in the
British study were older than in the current study
Table 1 Demographics of participants with NGJH (Non Generalised Joint Hypermobility), GJH (Generalised Joint Hypermobility) and
GJHS (GJH including shoulder joint hypermobility)
Variable All
(n = 989)
NGJH
(n = 689)
GJH
(n = 300)
p-value GJHS
(n = 51)
p-value
Women, % (no.) 55.9 (553) 47.3 (326) 75.7 (227) <0.001* 76.5 (39) <0.001*
Age, median (IQR) 50 (40–57) 50 (41–57) 48 (38–55.5) 0.025 46 (34–57) 0.145
BMI (Kg/m2), median (IQR) 25.4 (22.9–28.1) 25.5 (23.1–28.1) 25.1 (22.5–28.1) 0.151 24.5 (21.2–29.0) 0.284
Work-related status, % (no.) 0.188 0.149
Employed 71.2 (704) 72.3 (498) 68.7 (206) 54.9 (28)
Un-employed 3.74 (37) 3.34 (23) 4.67 (14) 3.92 (2)
Student 3.74 (37) 3.19 (22) 5.00 (15) 5.88 (3)
Absent because of illness 1.82 (18) 1.60 (11) 2.33 (7) 3.92 (2)
Early retired 3.94 (39) 3.19 (22) 5.67 (17) 7.84 (4)
Retired 4.15 (41) 4.06 (28) 4.33 (13) 7.84 (4)
Other 11.43 (113) 12.3 (85) 9.33 (28) 15.7 (8)
EuroQol VAS, median (IQR) 85 (75–90) 85 (75–90) 80 (70–90) <0.001* 75 (60–90) <0.001*
EQ-5D Index, median (IQR) 0.86 (0.77–1) 0.86 (0.78–1) 0.82 (0.74–0.86) <0.001* 0.79 (0.67–0.86) <0.001*
*Indicates a statistical significant difference (p-value <0.025) between participants with NGJH and GJH, and between NGJH and GJHS
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study), and thus recall bias of previous hypermobility
abilities may have been different in the two studies,
in addition to the fact that people become less hyper-
mobile with age [2]. An uneven sex ratio (in all 56%
women) is also likely a contributing factor to the
higher estimation of GJH in the current study, be-
cause the prevalence of GJH is higher in women than
in men [2]. However, the current sex ratio was similar
to both the British and the Brazilian studies [15, 17].
The prevalence of GJH is furthermore known to be
higher in non-Caucasians [43]. The Danish proportionTable 2 Crude (Model 1) and adjusted (Model 2) logistic regressions
musculoskeletal symptoms within the last 12 months, and for being
outside their home), due to musculoskeletal symptoms in the differe
presented for participants with GJH (Generalised Joint Hypermobility
NGJH (Non Generalised Joint Hypermobility) as reference group
Musculoskeletal
symptoms
last 12 mths
GJH
Model 1
OR (95% CI)
Model 2
OR (95% C
At individual sites
Neck 1.66 (1.24–2.23)* 1.34 (0.99–
Shoulders 1.68 (1.28–2.21)* 1.45 (1.09–
Elbows 1.33 (0.97–1.83) 1.29 (0.93–
Hands/wrists 2.49 (1.87–3.32)* 2.24 (1.67–
Prevented from performing their usual activities
Neck 2.09 (1.51–2.90)* 1.82 (1.30–
Shoulders 1.77 (1.28–2.44)* 1.55 (1.11–
Elbows 1.43 (0.88–2.31) 1.37 (0.83–
Hands/wrists 2.02 (1.39–2.94)* 1.82 (1.23–
*Indicates a p-value <0.025of immigrants and their descendants (non-Caucasians)
did only account for 11.6% of the total population at
the time of the study, making the current study
population fairly homogeneous with respect to ethni-
city (Statistics Denmark, 2015). Thus a higher rate of
non-Caucasians seems not likely to be a reason for
the higher prevalence of GJH in Denmark than in the
UK.
The prevalence of GJHS was 5%, but to our knowledge
there has not been another study that has examined the
prevalence of shoulder joint hypermobility in combin-
ation with GJH. Since neither the most often used, with odds ratio (OR) and 95% confidence interval (95% CI), for
prevented from performing their usual activities (at home/
nt body regions (neck, shoulders, elbows, hand/wrists)
) and GJHS (GJH including shoulder joint hypermobility), with
GJHS
I)
Model 1
OR (95% CI)
Model 2
OR (95% CI)
1.82) 1.77 (0.94–3.33) 1.49 (0.78–2.84)
1.92)* 3.79 (1.95–7.37)* 3.37 (1.72–6.58)*
1.80) 2.14 (1.17–3.91)* 2.08 (1.13–3.83)*
3.01)* 3.96 (2.22–7.08)* 3.53 (1.96–6.35)*
2.56)* 4.94 (2.75–8.90)* 4.41 (2.43–8.00)*
2.18)* 3.75 (2.08–6.75)* 3.35 (1.84–6.09)*
2.26) 2.86 (1.32–6.23)* 2.83 (1.28–6.27)*
2.69)* 2.60 (1.30–5.18)* 2.36 (1.17–4.76)*
Table 3 Crude (Model 1) and adjusted (Model 2) logistic regressions, with odds ratio (OR) and 95% confidence interval (95% CI), for
problems in Health Related Quality of Life in the EQ-5D-5 L dimensions, presented for participants with Non Generalised Joint
Hypermobility (NGJH) compared with GJH, and for NGJH compared with GJHS (GJH including shoulder joint hypermobility)
GJH GJHS
EQ-5D-5 L dimensions Model 1
OR (95% CI)
Model 2
OR (95% CI)
Model 1
OR (95% CI)
Model 2
OR (95% CI)
Mobility 1.48 (1.07–2.04)* 1.47 (1.05–2.06)* 3.36 (1.87–6.04)* 3.39 (1.87–6.16)*
Self-care 1.80 (1.14–2.86)* 1.83 (1.13–2.95)* 3.33 (1.57–7.07)* 3.49 (1.61–7.54)*
Usual activities 1.81 (1.36–2.41)* 1.85 (1.38–2.49)* 3.22 (1.81–5.73)* 3.35 (1.87–6.02)*
Pain/discomfort 1.81 (1.35–2.42)* 1.69 (1.25–2.28)* 2.98 (1.47–6.05)* 2.81 (1.38–5.73)*
Anxiety/depression 1.42 (1.04–1.94) 1.38 (1.00–1.91) 1.86 (1.01–3.42) 1.81 (0.97–3.36)
* Indicates a p-value <0.025
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score), nor the 5-PQ include a specific test/question for
shoulder joint hypermobility, the current addition of a
question targeting specifically the shoulder provides in-
formation that was previously unknown.
Generally, participants with GJH were significantly
more likely to report musculoskeletal symptoms in the
upper part of the body than NGJH. This is similar to
previous studies that reported significant associations
with musculoskeletal symptoms in GJH compared with
NGJH [2, 8, 17, 18]. The severity of musculoskeletal
symptoms was obvious in the current study, illustrated
by the high proportion of participants with GJH/GJHS
being prevented from performing their usual activities,
and the proportion reporting chronic musculoskeletal
symptoms (more than 90 days per year). The most fre-
quent body regions preventing participants with GJHS
from performing their usual activities (in/outside home)
and with more than 90 days of symptoms were the
shoulder and neck regions, possibly due to the hypermo-
bile shoulder condition. Although GJH is a well-known
risk factor for joint dislocation and soft tissue injuries
(e.g. muscle, tendon and ligament injuries) [2], the infor-
mation of the high presence of musculoskeletal symp-
toms among participants with GJH in Denmark and
especially GJHS is new. It was anticipated that GJHS
would be associated with musculoskeletal symptoms, es-
pecially in the shoulder, and this was mostly confirmed
in the current study. Not surprisingly, participants with
GJHS had about three fold higher odds of musculoskel-
etal symptoms in the shoulder and neck than NGJH.
Symptoms in all other upper body regions could be due
to compensatory movements resulting in overload.
The low HRQoL scores in participants with GJH are
in agreement with a previous study of patients diagnosed
with Ehlers Danlos Syndrome, Hypermobile Type [19],
but even lower HRQoL in participants with GJHS has
not been previously reported. Both patients diagnosed
with shoulder instability and more severe conditions of
hypermobility (e.g. Joint Hypermobility Syndrome andEhlers Danlos Syndrome-Hypermobile Type) have been
found to be associated with severely reduced HRQoL
compared with NGJH [18, 44], which seems to support
the current reduced HRQoL, especially in those with
GJHS. Noteworthy and surprisingly, the EQ-5D-5 L’s
physical activity dimension had the highest OR for de-
creased HRQoL in participants with GJHS. This under-
lines the high physical impact GJH and GJHS has on
participants’ life. The current study found no associa-
tions for GJH and GJHS with the mental-related dimen-
sion of anxiety/depression, which has previously been
reported in patients with Ehlers Danlos Syndrome,
Hypermobile Type [19]. However, a recent study did also
find no significant association between patients with
Joint Hypermobility Syndrome/Ehlers Danlos Syndrome,
Hypermobile Type and mental health, thereby support-
ing the current results further [18]. One of the reasons
for the conflicting results of the impact GJH has on
mental health [19] may be due to different methods of
measuring mental health (the current one dimension of
the EQ-5D-5 L versus the previously used four dimen-
sions in SF-36).
The current response rate of 49% was fairly high, given
only two reminders, and that the participants had to ini-
tiate the response to the electronic questionnaire, and it
was actually higher than in the mentioned British
population-based study (28%) [17]. Since the study had a
focus on joint hypermobility, participants with no signs
or knowledge of hypermobility may have been less likely
to answer the questionnaire, with a risk of overestimat-
ing the prevalence. Unfortunately, since the random
sample only included names and home addresses, no
drop out analyses could be performed on demographics.
However, previous studies using the same method (no
aggressive protocol, no incentives, no sponsor sender,
the national survey) have shown no response rate bias
with regards to low response rates and skewed demo-
graphics (age, sex, marital status, education) [45, 46].
Selection bias was anticipated not to have influenced
the results in relation to musculoskeletal symptoms and
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etal symptoms and activity limitations for the partici-
pants were in accordance with previous studies [17–19,
22], as was the distribution of responses to the HRQoL
[18, 39, 40, 47, 19]. With the relatively long recall pe-
riods for both GJH (5-PQ: ever/now) and musculoskel-
etal symptoms (SNQ: last 12 months) recall bias may be
present, but this does not seem likely, since satisfactory
psychometric properties (reliability and validity) have
been reported for both 5-PQ and SNQ [3, 15, 30, 32].
Although previous studies have investigated HRQoL
and musculoskeletal symptoms in participants with Joint
Hypermobility Syndrome/Ehlers Danlos Syndrome,
Hypermobile Type, no previous study has used the SNQ
and EQ-5D-5 L in a population-based study of GJH and
GJHS. This makes it difficult directly to compare the
current data with other studies.
The strength of this study was the random selection of
the study sample at the population level and the extrac-
tion of data through a governmental institution, which
resulted in a representative sample of adults living in
Denmark during the study period. Furthermore, with the
exception of the additional question on GJHS, only vali-
dated questionnaires were used in the current
population-based survey [3, 40, 48–50]. Since both un-
adjusted and adjusted models showed almost the same
pattern of significance, the current findings and associa-
tions appear to be consistent.Conclusions
GJH and GJHS are frequently self-reported musculoskel-
etal conditions in the general adult population. Com-
pared with NGJH, GJH and especially GJHS present
with higher odds and severity of upper body musculo-
skeletal symptoms and decreased HRQoL. Also, there is
a need to study the prevalence of GJH including lower
extremity hypermobility and the association to lower
body musculoskeletal symptoms. Further, since the
current study is a cross-sectional study, longitudinal
studies are recommended to describe the onset, fluctua-
tions and persistence of chronic musculoskeletal symp-
toms and osteoarthritis in the general adult population,
and how musculoskeletal symptoms are associated with
GJH through the life course.
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